"Global Efforts Ramp Up for Bird Flu Vaccination Amid Outbreak Concerns"

CSL Sequirus has secured a federal contract to produce nearly 5 million doses of H5N1 bird flu vaccines at its Holly Springs facility, aiming to preemptively address potential outbreaks. The company is prepared to quickly distribute the vaccine, especially to those at high risk, such as individuals in direct contact with birds or animals. This initiative follows multiple contracts with BARDA, emphasizing the company's role in pandemic preparedness.